SCHEMBL19295407

SCHEMBL19295407

C/C=C(\C=C/CO)/C=C/c1cc(O)cc(OC)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 2/20 0.57
▸ CYP1A1 P04798 6/20 0.50
▸ CYP1B1 Q16678 6/20 0.50
▸ PTGS2 P35354 3/20 0.50
▸ ALOX5 P09917 3/20 0.50
▸ TTR P02766 2/20 0.50
▸ MAPT P10636 4/20 0.49
▸ KDM4E B2RXH2 3/20 0.49
▸ MEN1 O00255 3/20 0.49
▸ KMT2A Q03164 3/20 0.49
▸ USP2 O75604 1/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ TP53 P04637 1/20 0.49
▸ CYP3A4 P08684 1/20 0.49
▸ HPGD P15428 1/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ TRPV1 Q8NER1 1/20 0.49
▸ HSD17B10 Q99714 1/20 0.49
▸ APP P05067 1/20 0.46
▸ ABL1 P00519 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4679569 0.82 CYP1A1 (0.61) BACE1CYP1A1CYP1B1PTGS2ALOX5
SCHEMBL4679562 0.82 CYP1A1 (0.61) BACE1CYP1A1CYP1B1PTGS2ALOX5
SCHEMBL16418365 0.81 MAOB (0.51) CYP1A1CYP1B1MAPTHPGDSMN1; SMN2
SCHEMBL19295406 0.74 BACE1 (0.38) BACE1ALOX5MAPTMEN1KMT2A
SCHEMBL9605433 0.73 CYP1A1 (0.67) BACE1CYP1A1CYP1B1PTGS2ALOX5
SCHEMBL28981586 0.73 CYP1A1 (0.64) CYP1A1CYP1B1PTGS2ALOX5TTR
SCHEMBL28981584 0.73 CYP1A1 (0.64) CYP1A1CYP1B1PTGS2ALOX5TTR
SCHEMBL3222916 0.73 BACE1 (1.00) BACE1CYP1A1CYP1B1PTGS2ALOX5
SCHEMBL3222937 0.73 BACE1 (1.00) BACE1CYP1A1CYP1B1PTGS2ALOX5
SCHEMBL14416282 0.73 CYP1A1 (0.61) BACE1CYP1A1CYP1B1PTGS2ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170247612-A1 WATER-SOLUBLE FLUORESCENCE COMPOUND AND METHOD FOR PREPARING THE SAME SNU R&DB FOUNDATION (KR) 2017-08-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170247612-A1 WATER-SOLUBLE FLUORESCENCE COMPOUND AND METHOD FOR PREPARING THE SAME WNT3A, VDR, SI BACE1 1921/4885CYP1A1 107/4885CYP1B1 243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback